Abstract-An ecto-ATPase has been described in human leukocytes. The enzyme is present in both granulocytes and lymphocytes, exhibiting higher activity and substrate affinity in the latter cells, I$,, values ranged from 0.06 mM in lymphocytes to 0.3 mM in the unresolved leukocyte fraction. Enzymatic activity had a pH optimum in the physiological range, required MgZc, and was insensitive toward ouabain and Ca2*. Potent inhibitors of ecto-ATPase were tricyclic antidepressants and substituted phenothiazines, to which the enzyme in lymphocytes was most susceptible. These drugs also decreased the phagocytic ability of leukocytes. However, while drug inhibition of the enzyme was reversible by washing, the effect dn phagocytosis was not.
We have described previously an ecto-ATPase in rat leukocytes and reported the potent inhibition of the enzymatic activity by tricyclic antidepressants and substituted phenothiazines [l, 21. These drugs also markedly inhibited phagocytosis [3] . The inhibitory effects were not reproduced by a variety of drugs of different structures, investigated at identical concentrations. In human platelets, inhibition of ectoATPase has been linked to the loss of aggregating ability [4] . Our preliminary work provided evidence for the existence of ecto-ATPase in human leukocytes [S] . In view of the unknown function of this enzyme, and considering its potent inhibition by a number of drugs of wide ciinical use, it was of interest to investigate further the properties of the ectoATPase in human leukocytes, including granulocytes and lymphocytes, and to characterize its interaction with drugs.
MATERIALS AND METHODS
M&Gals. The drugs used in this study were provided by Dr. H. H. Swain, Department of Pharmacology, The University of Michigan. The biochemicals and enzymes were purchased from the Sigma Chemical Co., St. Louis, MO, and from the Boehringer Mannhein Co., Indianapolis, IN. Plasmagel and Isolymph, solutions utilized for cell isolation, were purchased from the HTI Corp., Buffalo, NY and from Gallard-Schlesinger, Carle Place, NY, respectively.
Isolation of cells. Blood was obtained by venipuncture from healthy male and female volunteers not taking medications. Leukocytes were isolated according to a previously described procedure yielding celh of high purity and long term viability in vitro [6] . Granulocytes and lymphocytes were obtained by a recently developed method for the *Author to whom correspondence should be addressed. monument isolation of these cells from the same sample of blood, focusing again on high purity and viability, particularly concerning plasma membrane integrity [7] .
Buffer media and handling of cells. Many of the experimental steps were described previously in our study of this enzymatic activity in rat leukocytes [l, 21. Freshly isolated leukocytes, ~ranulocytes or lymphocytes were suspended in a medium with the following composition (mM): Na+, 155.7; K', 4.9; M$+, 1.2; Cl-, 131.3; SO:-, 1.2; HPO,Z-, 13.3; and HzPO.,-', 2.7. These concentrations include the amounts of Cl-and Na+ needed for pH adjustment. The medium was prepared as follows: 0.77 M NaCI, 200 ml; 0.77 MKCl, 8 ml; 0.77 MMgS04, 2 ml;&5 M Na2HP04 buffer, adjusted to pH 7.4 with HCl, 40 ml; and H20, 1000ml. Glucose, in amounts to give 10 mM final concentration, was added in solid form to aliquots of the above medium. The final pH of the medium was adjusted to 7.4 with NaOH. In genera& the freshly isolated cells were incubated for 60 min at 37" prior to starting the particular experiment. After the cell count was determined, the suspension was centrifuged at 80 g for 7 min and the pellet was resuspended at 37" to the required cell concentration with a buffer medium of the following composition (mM): Tris, 35; NaCl, 120; KCl, 5; MgC&, 2.5; and glucose, 10. The pH of the medium was adjusted to 7.4 with HCl.
Enzvme kinetics and inhibition. For the cleterminatiocof kin&c-constants (K,,,, V,,,), 50 yl of cell suspension in the Tris-based medium and 50~1 of the medium containing ATP at twice the final concentration desired were pipetted into 1.5 ml polyethyIene tubes (Eppendorf MicroanaIytical System). Mixing of these solutions represented the beginning of the enzyme assay. The latter was terminated at 30 min by the addition of 400 ~1 of ice-cold 0.6 M HClO,. The tubes were centrifuged for 10min at 1900 g in the cold, and inorganic phosphate (Pi) was determined in the supernatant fraction by a procedure described previously [ 11.
Briefly, aliquots of 250 ~1 were placed in 4 ml tubes, and 250 ~1 of a color reagent was added. The composition of the latter was 144 mM FeSOd in 8.15 mM ammonium molybdate/580 mM H2SOJ. The absorbance of the samples at 700 nm was determined within the linear range of the standard curve, established by using potassium phosphate. Blanks, containing either ATP and no biological material or of the opposite composition, were included in each assay. Some of the drugs used in this study interfered in the calorimetric determination of P,. In such cases, Pi was quantitated by an enzymatic method using phosphorylase a, phosphoglucomutase and glucose-6-phosphate dehydrogenase to measure fluorometrically the formation of reduced nicotinamide adenine dinucleotide phosphate [S] . If P, was determined by the latter method [l] , the ATPase reaction was terminated by placing the tubes in a boiling water bath for 8 min, followed by centrifugation at 1900 g for 10 min. Aliquots of the supernatant fluid were added to 1 ml of the prepared reagent containing all the necessary components except for phosphorylase. After mixing and taking the initial reading of fluorescence, the reaction was started by the addition of the latter enzyme. The rate of enzymatic reaction was monitored on a recorder. After its completion, the second reading of all the samples was taken. Appropriate standards of Pi were included in each set of analyses.
In experiments on enzyme inhibition, the methodology outlined above was followed in general with the following exceptions. To 40+1 aliquots of the cell suspension was added 10 ~1 of a solution of the drugs in the buffer medium at concentrations five times that utilized during the assay. The suspension was subsequently incubated for 15 min at 37", at which time 50 1.11 of double-strength ATP solution was added and the assay mixture further incubated for 30 min. The subsequent steps were as outlined above. In other experiments, v&ious concentrations of cells corresponding to the amount of protein as indicated were incubated for 30min at 37". The further steps, including the assay of enzymatic activity, were carried out as described under Materials and Methods. Presented are the results of a representative experiment.
r
Determination of phagocytic index. Quantitation of phagocytosis was carried out as described 191. Briefly, 100~1 each of leukocyte suspension, fresh human serum, buffer medium and heat-killed Staphylococcus aureus in phosphate-buffered saline (to give a lo-fold excess of bacterial particles over the number of cells) were mixed at 0" using siliconized glassware. Cover slip preparations of the above mixture were incubated at 37" for 30 min in a moist chamber, and then dried and treated with Wright's stain. By microscopic examination at 2080 x magnification, the total number of particles ingested by 100 consecutively counted phagocytic cells was averaged and expressed as the phagocytic index.
Determination of protein. and extended above pH 8 before sharply declining (Fig. 2) . The insensitivity of the enzyme towards ouabain and metabolic inhibitors, and the strong inhibitory effect of EDTA (Table 2) were properties similar to those observed in rat leukocytes [2J. The specific dependence of the enzyme on Mg2+ was demonstrated, and an interference by glucose phosphate phosphatases was excluded. ATPase activity did not increase as a result of various procedures used to disrupt the plasma membrane ( Table 2 ). The ir, and V,, of ATPase in intact leukocytes was 0.32 mM and 1.83 pmolesimg protein/hr respectively (Fig. 2) .
While tricyclic antidepressants and substituted phenothiazines potently inhibited the ecto-ATPase (Table 3) , drugs of different structure had no effect on the enzyme. It was ascertained that ATPase inhibition can be obtained under conditions of unaltered plasma membrane permeability, as shown by the unchanged ratio of cellular R+/Na+ during the assay in the presence of the particular inhibiting drugs (Table 1) . On the other hand, several halogencontaining drugs that potently inhibited ecto-ATPase also induced a marked loss of cellular K+.
Inhibition of ecto-ATPase and the suppression of phagocytosis by drugs in human leukocytes exhibited a positive correlation (Table 3 ). Both phenomena * Shown are mean values of four experiments except for hypo-and hypertonicity, which were tested in two experiments, all run in triplicates. The standard deviation around the mean was in all cases less then 10 per cent.
i Cells were suspended in deionized water for 30 set at 37". $ Leukocytes were exposed to a 5-fold hypertonic Tris buffer medium for 30 set at 37".
5 Cells were rapidly frozen at -70" and thawed to room temperature. The cycle was carried out three times.
fi An all-glass Potter-Elvehjem homogenizer was used. Suspensions of leukocytes were incubated with and without 0.5 mM desipramine or 0.15 mM thioridazine for 15 min at 37". Subsequently, the cell suspension was centrifuged at 3000 g for 5 min and the supernatant fluid was decanted.
The pellet was resuspended with either buffer medium containing the drug at a concentration identical to that used in the incubation, or with buffer alone. After repeating the washing procedure, aliquots of the suspension were subjected to assay to ATPase activity and of phagocytosis as described under Materials and Methods. Presented are mean values of four experiments utilizing different preparations of the cells. In all experiments the standard deviation around the mean was less than + 5 per cent,
were assessed with cells from the same preparation of leukocytes. Enzyme inhibition by both tricyclic antidepressants and substituted phenothiazines was reversible (Fig. 3) . Although the degree of inhibition by desipramine and thioridazine was markedly different, the per cent recovery of enzymatic activity after washing was comparable. On the other hand, phagocytosis. inhibited by either desipramine or thioridazine, did not exhibit a trend toward recovery after washing of the cells (Fig. 3) . 
Characteristics of ecto-A TPase in granulocytes and
lymphocytes. It should be emphasized that these two populations of leukocytes were isolated concurrently from the same sample of blood. The kinetic constants of ecto-ATPase in granulocytes and lymphocytes were: K,, 0.12 mM and 0.06 mM, V,,,,,, 0.7 and 1.56 ,nmoles/mg proteinihr (Fig. 4) . The pattern of enzyme inhibition obtained with desipramine and promazine, representative of tricyclic antidepressants and substituted phenothiazines, was similar in both cell types (Fig. 5) . However, the enzyme in lymphocytes was more sensitive to drug inhibition. As observed with the unresolved fraction of leukocytes, phenothiazines were more potent inhibitors of ecto-ATPase.
Among the latter compounds, promazine was selected for this study because it inhibited the enzyme without affecting plasma membrane permeability (Table 1) . 
DISCUSSION
Ecto-ATPase activity was present in both granuiocytes and Iympho~ytes. Its lo~ai~ation was established by a~e~aining plasma membrane integrity during the course of the enzyme assay. The latter property was assessed by the cellular levels of K*, a sensitive criterion of plasma membrane perturbation [ll, 121. Furthermore, disruption of the cells by various methods did not lead to an increase of ATPase activity. Ecto-ATPase had been described previously in human platefets (41 and, in a preliminary communication,
we reported its presence in human leukocytes (51. subsequently, an ectoATPase in human granulocytes was reported 1131. In the present study, the characteristics of ectoATPase in human leukocytes were investigated, followed by a comparison of its properties in granulocytes and lymphocytes. The characteristics of the enzyme in human Ieukocytes were similar to those described for such enzymes in other cells (e.g. in Refs. 14-161, with the exception of a neuroblast~ma cell line in which ecto-ATPase was stimulated by Ca2+ 1171. The human feukocyte ecto-ATPase was dependent on Mg2+, had a pH optimum in the physiological range, and its rC, was 0.3 mM. Although information an ATP concentration in human plasma is equivocal, ranging from low FM levels to completely absent [ 151, in human blood the level of this compound reaches 1 mM (38f.
The effect on the enzyme of various inhibitors, including ouabain and metabolic poisons, was similar to that observed in rat leukocytes (Z] and in human gramdocytes (131. The most potent inhibition was obtained by N-ethylamaleimide, whereas Ca2+ moderately decreased the enzyme activity. A specific feature of ecto-ATPase in rat leukocytes was its inhibition by drugs [If. The corresponding human enzyme also exhibited this property, displaying a positive correlation between enzyme inhibition and suppression of phagocytosis. This phenomenon was not observed in human granufocytes, in which inhi-B.P. 29/17--e bition of eeto-ATPase by suramin did not impair phagoc~ic ability [13] . Our investigation of the link between leukocyte ecto-ATPase and phagocytosis was based an the assumedinvolvement ofthe enzyme in cell-specific surface phenomena, in analogy to the observed correlation in human platelets between inhibition of &to-ATPase and cell aggregation (4] . The observed inhibition by drugs of ecto-ATPase and of phagocytosis in leukocytes of the rat (33 and human (Table 3 ) led us to investigate the activity of the enzyme and its properties in both granulocytes and lymphocytes from human blood. The two types of leukocytes were separated from the same sample blood by a recently developed procedure yielding cell fraction of high purity [7] . Considering the virtual lack of cross-contamination, the possibility that the ecto-ATPase observed in this study in lymphocyres was due to contamination by granuiocytes can be excluded. Furthermore, compared to the latter ceils, the enzymatic activity in lymphocytes exhibited both high activity and affinity for its substrate and an increased sensitivity towards inhibitors. Although no previous information is availabie on ecto-ATPase in human leukocytes per se, the reported kinetic constants of the enzyme in granulocytes [13] agree well with those determined in this work. In general, &, values for ecto-ATPase from various sources range between 0.03 and 0.3 mM (e.g. Refs, 2, 15 and 17). On the other hand, a much greater difference exists in the reported data for V,,.
The inhibition by drugs occurred without changes in membrane permeability, as indicated by the unaltered cell content of K+ after exposure to drugs. However, several of the halogenated substituted phenothiazines, in addition to inhibiting the enzyme, greatly increased the permeability of the plasma membrane, suggesting ~rther-going drug-membrane interaction. In contrast to the partial reversal of enzyme inhibition by washing of the cells, this step had no effect on phagocytosis. Such dissociation of the two phenomena represents suggestive evidence for differences in the mechanisms by which drug inhibition of ecto-ATPase and of phagocytosis occurs. Although the effects of the tricyclic drugs on platelet ecto-ATPase have not been investigated, the inhibition of platelet aggregation by imipramine and chlo~rom~ine has been reported [19] . The inhibitory concentrations of the drugs (Table 3 ) were considerably higher then their therapeutic range, e.g. plasma leveis af combined desipramine and imipramine ranged between 107 and 698 ng/ml, the latter value ~rresponding to approximately 2.5 _uM [ZO]. However, non-specific protein binding of these drugs is substantial and thus their a~~mulat~on in tissues is likely (Zl] .
Conside~ng the ecto nature of leukocyte ATPase, any hypothesis on the ~nctionai role of this enzyme has to postulate the availabitity of extracellular ATP. While uncertainties exist about the concentration of ATP in plasma, its compartmentation within the plasma membrane, as suggested for platelets, cannot be ruled out [Z?]. Extracellular synthesis of ATP by various normal and malignant cell lines (231 and transfer of cytoplasm& ATP to the extracellular environment have been reported 1241. An additional aspect requiring clarification is the biological conse-quence of the hydrolysis of extracellular ATP by ecto-ATPase. Possible functional roles of such a process have been discussed, including the regulation of negative charges on cell surfaces [2.5] and an involvement in the blood clotting mechanism by providing extracellular ADP [lS] . Included in such considerations is a possible function of ecto-ATPase in granulocytes of hydrolyzing ATP derived from tissue damage, within the scavenger role of these cells. The involvement of ecto-ATPase in leukocyte aggregation, in analogy to such a relationship shown in platelets, has not been investigated. Although human granulocytes but not lymphocytes responded to chemotactic factors [26] , recently such a response was reported also for rat lymphocytes [27] . According to a recent report, extracellular ATP, at concentrations of 0.5 mM, increased passive plasma membrane permeability [28] , particularly of transformed cells [29] . It is of interest that this concentration of ATP correlates well with the observed K, values for leukocyte ecto-ATPases. By its involvement in the control of extracellular ATP, an ectoATPase could assume a role in regulating cell membrane permeability.
